Document:

EMR Technology Solutions, Inc. - 10-12G/A

Exhibit 4.1

EMR TECHNOLOGY
SOLUTIONS, INC.

2016 EQUITY INCENTIVE PLAN

1.       

Purpose.
The purpose of the plan is to provide incentives to attract, retain and motivate eligible persons (“Participant”) whose
present and potential contributions are important to the success of EMR TECHNOLOGY SOLUTIONS, INC. a Nevada corporation (the “Company”),
and its Subsidiaries and Affiliates, by offering them an opportunity to participate in the Company’s future performance through
award(s) (“Award(s)”) of Options and Restricted Stock. Capitalized terms not defined in the text are defined in Section
22.

2.       

Shares Subject to the Plan: Per-Person
Award Limitation.

2.1       

Number of
Shares Available. Subject to Sections 2.2 and 17, the total number of Shares reserved and available for grant and issuance pursuant
to the Plan shall be One Million and Five Hundred Thousand (1,500,000) Shares. Subject to Sections 2.2 and 17, Shares shall again
be available for grant and issuance in connection with future Awards under the Plan that: (a) are subject to issuance upon exercise
of an Option but cease to be subject to such Option for any reason other than exercise of such Option; (b) are subject to an Award
granted hereunder but are forfeited; or (c) are subject to an Award that otherwise terminates without Shares being issued. Subject
to Sections 2.2 and 17, in no event shall the aggregate number of Shares that may be issued pursuant to incentive stock options
exceed One Million and Five Hundred (1,500,000) Shares.

2.2       

Adjustment
of Shares. In the event that the number of outstanding Shares is changed by a stock dividend, recapitalization, stock split, reverse
stock split, subdivision or similar change in the capital structure of the Company without consideration, then: (a) the number
of Shares reserved for issuance under the Plan; (b) the Exercise Prices of and number of Shares subject to outstanding Options;
and (c) the number of Shares subject to other outstanding Awards shall be proportionately adjusted, subject to any required action
by the Board or the shareholders of the Company and in compliance with applicable securities laws.

2.3       

Individual
Award Limitation. Notwithstanding any other provision in this Plan, and in addition to any requirements of this Plan, the maximum
number of Shares granted hereunder to any one Participant may not exceed twenty percent (20%) of the total Shares subject to the
Plan (subject to adjustments as provided in Sections 2.2 and 17 hereof).

3.       

Eligibility.

3.1       

General.
All Awards set forth herein may be granted to employees, officers, directors, consultants and advisors of the Company or any Parent,
Subsidiary or Affiliate of the Company, provided such consultants and advisors render bona fide services not in connection with
the offer and sale of securities in a capital-raising transaction. A person may be granted more than one Award under the Plan.

4.       

Administration.

4.1       

Compensation
Committee. The Plan shall be administered by a committee (“Committee”) appointed by the Company’s Board of Directors.
The membership of the Committee shall be constituted so as to comply at all times with the then applicable requirements for “outside
directors” of Rule 16b-3 promulgated under the Exchange Act and Section 162(m) of the Code. Any determination made by the
Committee with respect to any Award shall be made in its sole discretion at the time of grant
of the Award or, unless in contravention of any express term of the Plan or Award, at any later time, and such determination shall
be final and binding on the Company and all persons having an interest in any Award under the Plan.

    	 

    	 

    

 

4.2       

Committee
Authority. Subject to the general purposes, terms and conditions of the Board, the Committee shall have full power to implement
and carry out the Plan. The Committee may delegate to one or more officers of the Company the authority to make recommendations
to grant an Award under the Plan to Participants who are not Insiders of the Company. The Committee shall have the authority to:

(a)       

construe and interpret the Plan, any Award Agreement
and any other agreement or document executed pursuant to the Plan;

(b)       

recommend to the Board amendments
to the rules and regulations relating to the Plan;

(c)       

select the persons to receive Awards;

(d)       

determine the form and terms of
Awards;

(e)       

determine the number of Shares or
other consideration subject to Awards;

(f)       

determine whether Awards will
be granted singly, in combination, in tandem with, in replacement of, or as alternatives to, other Awards under the Plan or any
other incentive or compensation plan of the Company or any Parent, Subsidiary or Affiliate of the Company;

(g)       

determine the granting of certain
waivers of Plan or Award conditions;

(h)       

determine the conditions concerning
the vesting, exercisability and payment of Awards;

(i)       

recommend to the Board such matters so as to correct
any defect, supply any omission, or reconcile any inconsistency in the Plan, any Award or any Award Agreement;

(j)       

determine whether an Award has been
earned; and

(k)       

make all other determinations necessary
or advisable for the administration of the Plan.

4.3       

Exchange Act Requirements. If
the Company is subject to the Exchange Act, the Company will take appropriate steps to comply with the disinterested director requirements
of Section 16(b) of the Exchange Act, including but not limited to, the appointment by the Board of a committee consisting of not
less than two persons (who are members of the Board), each of whom is a Disinterested Person.

4.4       

Address of Committee. The Committee’s
address to which any correspondence or notifications may be sent or given is:

EMR TECHNOLOGY SOLUTIONS, INC.

90 Washington Valley Road

Bedminster, NJ 07921

Attention: Chief Executive Officer

5.       

Options.
The Committee may grant Options to eligible persons such Incentive Stock Options the meaning of the Code (‘‘ISO’’),
the number of Shares subject to the Option, the Exercise Price of the Option, the period during which the Option may be exercised,
and all other terms and conditions of the Option, subject to the following:

5.1       

Form of
Option Grant. Each Option granted under the Plan shall be evidenced by an Award Agreement which shall expressly identity the Option
as an ISO (“Stock Option Agreement”), and be in such form and contain such provisions (which need not be the same for
each Participant) as the Committee shall from time to time approve, and which shall comply with and be subject to the terms and
conditions of the Plan.

    	 

    	 

    

 

5.2       

Date of
Grant. The date of grant of an Option shall be the date on which the Committee makes the determination to grant such Option, unless
otherwise specified by the Committee. The Stock Option Agreement and a copy of the Plan will be delivered to the Participant within
a reasonable time after the granting of the Option.

5.3       

Exercise Period.
Options shall be exercisable within the times or upon the events determined by the Committee as set forth in the Stock Option Agreement;
provided, however, that no Option shall be exercisable after the expiration of ten (10) years from the date the Option is granted,
and provided further that no Option granted to a person who directly or by attribution owns more than ten percent (10%) of the
total combined voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company (‘‘Ten
Percent Shareholder”) shall be exercisable after the expiration of five (5) years from the date the Option is granted. The
Committee also may provide for the Options to become exercisable at one time or from time to time, periodically or otherwise, in
such number or percentage as the Committee determines.

5.4       

Exercise
Price. The Exercise Price shall be determined by the Committee when the Option is granted and may be not less than the par
value of a Share on the date of grant provided that: (i) the Exercise Price of an ISO shall be not less than one hundred
percent (100%) of the Fair Market Value of the Shares on the date of grant; (ii) the Exercise Price of any ISO granted to a
Ten Percent Shareholder shall not be less than one hundred ten percent (110%) of the Fair Market Value of the Shares on the
date of grant; and (iii) the Exercise Price of any option granted that the Committee intends to quality under Section 162(m)
of the Code, shall not be less than one hundred percent (100%) of the Fair Market Value of the Shares on the date of grant.
Payment for the Shares purchased may be made in accordance with Section 7 of the Plan.

5.5       

Method of
Exercise. Options may be exercised only by delivery to the Company of a written stock option exercise agreement (the “Exercise
Agreement.,) in a form approved by the Committee (which need not be the same for each Participant), stating the number of Shares
being purchased, the restrictions imposed on the Shares, if any, and such representations and agreements regarding Participant’s
investment intent and access to information and other matters, if any, as may be required or desirable by the Company to comply
with applicable securities laws, together with payment in full of the Exercise Price for the number of Shares being purchased.

5.6       

Termination.
Unless otherwise set forth in the Stock Option Agreement, the exercise of an Option shall be subject to the following:

(a)       

If the Participant
is Terminated for any reason except death or Disability, then Participant may exercise such Participant’s Options only to
the extent that such Options would have been exercisable upon the Termination Date no later than three (3) months after the Termination
Date (or such shorter time period as may be specified in the Stock Option Agreement), but in any event, no later than the expiration
date of the Options.

(b)       

If the Participant
is terminated because of death or Disability (or the Participant dies within three (3) months of such termination), then Participant’s
Options may be exercised only to the extent that such Options would have been exercisable by Participant on the Termination Date
and must be exercised by Participant (or Participant’s legal representative or authorized assignee) no later than twelve
(12) months after the Termination Date (or such shorter time period as may be specified in the Stock Option Agreement), but in
any event no later than the expiration date of the Options.

    	 

    	 

    

 

5.7       

Limitations
on Exercise. The Committee may specify a reasonable minimum number of Shares that may be purchased on any exercise of an Option,
provided that such minimum number will not prevent Participant from exercising the Option for the full number of Shares for which
it is then exercisable.

5.8       

Modification.
Extension or Renewal. The Committee may modify, extend, or renew outstanding Options and authorize the grant of new Options in
substitution therefore, provided that any such action may not without the written consent of Participant, impair any of Participant’s
rights under any Option previously granted. Any outstanding ISO that is modified, extended, renewed or otherwise altered shall
be treated in accordance with Section 424(h) of the Code.

The Committee may reduce the
Exercise Price of outstanding Options without the consent of Participants affected by a written notice to them; provided, however,
that the Exercise Price may not be reduced below the minimum Exercise Price that would be permitted under Section 5.4 of the Plan
for Options granted on the date the action is taken to reduce the Exercise Price.

5.9       

No Disqualification.
Notwithstanding any other provision in the Plan, no term of the Plan relating to ISOs shall be interpreted, amended or altered,
nor shall any discretion or authority granted under the Plan be exercised, so as to disqualify the Plan under Section 422 of the
Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.

6.       

Payment for Share Purchases.

6.1       

Payment.
Payment for Shares purchased pursuant to the Plan may be made in cash (by check) or, where expressly approved for the Participant
by the Committee and where permitted by law:

(a)       

by cancellation
of indebtedness of the Company to the Participant;

(b)       

by transfer
of Shares that either (1) have been owned by Participant for more than six (6) months and have been paid for within the meaning
of SEC Rule 144; or (2) were obtained by Participant in the public market;

(c)       

by waiver
of compensation due or accrued to Participant for services rendered; (d) by tender of property;

(e)       

with a promissory
note in favor of the Company, which such note shall (1) provide for full recourse to the maker, (2) be collateralized by the pledge
of the Shares that the Optionee purchases upon exercise of the Option, (3) bear interest at the prime rate of the Company’s
principal lender, and (4) contain such other terms as the Committee in its sole discretion shall reasonably require;

(f)       

by a “cashless
exercise” in which Shares which would otherwise be delivered upon exercise of the Option may be used to satisfy the payment
of the exercise price of the Option, in accordance with the following formula:

X=Y (A-B)

A

    	 

    	 

    

 

Where:

X = the number of Shares to be issued
to Optionee.

Y =the number of Shares purchasable
under the amount of the Option being exercised A = the per Share Fair Market Value

B =the per Share Exercise Price of
the Option

(g)       

with respect
only to purchases upon exercise of an Option, and provided that a public market for the Company’s stock exists:

(1)       

through
a “same day sale” commitment from Participant and a broker-dealer that is a member of the National Association of Securities
Dealer (an ‘‘NASD Dealer”) whereby the Participant irrevocably elects to exercise the Option and to sell a portion
of the Shares so purchased to pay for the Exercise Price, and whereby the NASD Dealer irrevocably commits upon receipt of such
Shares to forward the Exercise Price directly to the Company; or

(2)       

through
a “margin” commitment from Participant and an NASD Dealer whereby Participant irrevocably elects to exercise the Option
and to pledge the Shares so purchased to the NASD Dealer in a margin account as security for a loan from the NASD Dealer in the
amount of the Exercise Price, and whereby the NASD Dealer irrevocably commits upon receipt of such Shares to forward the exercise
price directly to the Company; or

(h)       

by any combination of the foregoing.

If the Exercise Price or purchase
price is paid in whole or in part with Shares, or through the withholding of Shares issuable upon exercise of the Option, the value
of the Shares surrendered or withheld shall be their Fair Market Value on the date the Option is exercised.

7.       

Withholding Taxes.

7.1       

Withholding
Generally. Whenever Shares are to be issued in satisfaction of Awards granted under the Plan, the Company may require the Participant
to remit to the Company an amount sufficient to satisfy federal, state and local withholding tax requirements prior to the delivery
of any certificate or certificates for such Shares. Whenever, under the Plan, payments in satisfaction of Awards are to be made
in cash, such payment shall be net of an amount sufficient to satisfy federal, state, and local withholding tax requirements.

7.2       

Stock Withholding.
When, under applicable tax laws, a Participant incurs tax liability in connection with the exercise or vesting of any Award that
is subject to tax withholding and the Participant is obligated to pay the Company the amount required to be withheld, the Committee
may allow the Participant to satisfy the minimum withholding tax obligation by electing to have the Company withhold from the Shares
to be issued that number of Shares having a Fair Market Value equal to the minimum amount required to be withheld, determined on
the date that the amount of tax to be withheld is to be determined (the “Tax Date”).All elections by a Participant
to have Shares withheld for this purpose shall be made in writing in a form acceptable to the Committee and shall be subject to
the following restrictions:

(a)       

the election
must be made on or prior to the applicable Tax Date;

    	 

    	 

    

 

(b)       

once
made, then except as provided below, the election shall be irrevocable as to the particular Shares as to which the election is
made;

(c)       

all elections shall be subject to
the consent or disapproval of the Committee;

(d)       

if the Participant
is an Insider and if the Company is subject to Section 1 6(b) of the Exchange Act: (1) the election may not be made within six
(6) months of the date of grant of the Award, except as otherwise permitted by SEC Rule 1 6b-3(e) under the Exchange Act, and

(2) either (A) the election
to use stock withholding must be irrevocably made at least six (6) months prior to the Tax Date (although such election may be
revoked at any time at least six (6) months prior to the Tax Date) or (B) the exercise of the Option or election to use stock withholding
must be made in the ten (10) day period beginning on the third day following the release of the Company’s quarterly or annual
summary statement of sales or earnings; and

(e)       

in the event
that the Tax Date is deferred until six (6) months after the delivery of Shares under Section 83(b) of the Code, the Participant
shall receive the full number of Shares with respect to which the exercise occurs, but such Participant shall be unconditionally
obligated to tender back to the Company the proper number of Shares on the Tax Date.

8.       

Privileges
of Stock Ownership. No Participant shall have any of the rights of a shareholder with respect to any Shares until the Shares are
issued to the Participant. After Shares are issued to the Participant, the Participant shall be a shareholder and have all the
rights of a shareholder with respect to such Shares, including the right to vote and receive all dividends or other distributions
made or paid with respect to such Shares; provided, that if such Shares are Restricted Stock, then any new, additional or different
securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split
or any other change in the corporate or capital structure of the Company shall be subject to the same restrictions as the Restricted
Stock.

9.       

Transferability.
Awards granted under the Plan, and any interest therein, shall not be transferable or assignable by Participant, and may not be
made subject to execution, attachment or similar process, otherwise than by will or by the laws of descent and distribution or
as consistent with the specific Plan and Award Agreement provisions relating thereto. During the lifetime of the Participant an
Award shall be exercisable only by the Participant, and any elections with respect to an Award, may be made only by the Participant.

10.       

Restrictions
on Shares. At the discretion of the Committee, the Company may reserve to itself and/or its assignee(s) in the Award Agreement
a right of first refusal to purchase all Shares that a Participant (or a subsequent transferee}may propose to transfer to a third
party.

11.       

Certificates.
All certificates for Shares or other securities delivered under the Plan shall be subject to such stock transfer orders, legends
and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable federal, state
or foreign securities law, or any rules, regulations and other requirements of the SEC or any stock exchange or automated quotation
system upon which the Shares may be listed.

12.       

Escrow:
Pledge of Shares. To enforce any restrictions on a Participant’s Shares, the Committee may require the Participant to deposit
all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately
endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed
or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates.

    	 

    	 

    

 

13.       

Exchange
and Buy out of Awards. The Committee, may, at any time or from time to time, authorize the Company, with the consent of the respective
Participants, to issue new Awards in exchange for the surrender and cancellation of any or all outstanding Awards. The Company
may at any time buy from a Participant an Award previously granted with payment in cash, Shares (including Restricted Stock) or
other consideration, based on such terms and conditions as the Company and the Participant shall agree.

14.       

Securities
Law and Other Related Compliance. An Award shall not be effective unless such Award is in compliance with all applicable federal
and state securities laws, rules and regulations of any governmental body, and the requirements of any stock exchange or automated
quotation system upon which the Shares may then be listed, as they are in effect on the date of grant of the Award and also on
the date of exercise or other Issuance.

Notwithstanding any other provision
in the Plan, the Company shall have no obligation to issue or deliver certificates for Shares under the Plan prior to: (a) obtaining
any approvals from governmental agencies that the Company determines are necessary or advisable, and/or (b) completion of any registration
or other qualification of such shares under any state or federal law or ruling of any governmental body that the Company determines
to be necessary or advisable. The Company shall be under no obligation to register the Shares with the SEC or to effect compliance
with the registration, qualification or listing requirements of any state securities laws, stock exchange or automated quotation
system, and the Company shall have no liability for any inability or failure to do so.

15.       

No Obligation
to Employ. Nothing in the Plan or any Award granted under the Plan shall confer or be deemed to confer on any Participant any right
to continue in the employ o±: or to continue any other relationship with, the Company or any Parent, Subsidiary or Affiliate
of the Company or limit in any way the right of the Company or any Parent, Subsidiary or Affiliate of the Company to terminate
Participant’s employment or other relationship at any time, with or without cause.

16.       

Corporate Transactions.

16.1       

Assumption
or Replacement of Awards by Successor. In the event of (a) a merger or consolidation in which the Company is not the surviving
corporation (other than a merger or consolidation with a wholly-owned subsidiary, a reincorporation of the Company in a different
jurisdiction, or other transaction in which there is no substantial change in the shareholders of the company and the Awards granted
under the Plan are assumed or replaced by the successor corporation, which assumption shall be binding on all Participants); (b)
a dissolution or liquidation of the Company; (c) the sale of substantially all of the assets of the Company; or (d) any other transaction
which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the shareholders of the Company
give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of
the outstanding shares of the Company), all outstanding Awards may, to the extent permitted by applicable law, be replaced by the
successor corporation (if any) with Awards of equivalent value, which replacement shall be binding on all Participants. In the
alternative, substantially similar consideration may be provided to Participants as was provided to shareholders (after taking
into account the existing provisions of the Awards). The successor corporation may also issue, in place of outstanding Shares of
the Company held by the Participant, substantially similar shares or other property subject to repurchase restrictions no less
favorable to the Participant.

    	 

    	 

    

 

16.2       

Other Treatment
of Awards. Subject to any greater rights granted to Participants under the foregoing provisions of this Section 17, in the event
of the occurrence of any transaction described in Section 17.1, any outstanding Awards shall be treated as provided in the applicable
agreement or plan of merger, consolidation, dissolution, liquidation, sale of assets or other “corporate transaction.”

16.3       

Assumption
of Awards by the Company. The Company, from time to time, also may grant Awards identical to awards granted by another company,
whether in connection with an acquisition of such other company or otherwise, by granting an Award under the Plan in replacement
of such other company’s award. Such replacement shall be permissible if the holder of the replaced award would have been
eligible to be granted an Award under the Plan if the other company had applied the rules of the Plan to such grant. In the event
the Company grants Awards identical to an award granted by another company, the terms and conditions of such award shall remain
unchanged (except that the exercise price and the number and nature of Shares issuable upon exercise of any such option will be
adjusted approximately pursuant to Section 424(a) of the Code).

17.       

Adoption
and Shareholder Approval. The Plan shall become effective on the date that it is adopted by the Board (the “Effective Date”).
The Plan shall be approved by the shareholders of the Company (excluding Shares issued pursuant to this Plan), consistent with
applicable laws, within twelve months before or after the Effective Date. Upon the Effective Date, the Committee may grant Awards
pursuant to the Plan; provided, however, that: (a) no Option may be exercised prior to initial shareholder approval of the Plan;
(b) no Option granted pursuant to an increase in the number of Shares approved by the Board shall be exercised prior to the time
such increase has been approved by the shareholders of the Company; and in the event that shareholder approval is not obtained
within the time period provided herein, all Awards granted hereunder shall be canceled, any Shares issued pursuant to any Award
shall be canceled and any purchase of Shares hereunder shall be rescinded. After the Company becomes subject to Section 16(b) of
the Exchange Act, the Company will comply with the requirements of Rule 16b-3 (or its successor), as amended, with respect to shareholder
approval.

18.       

Term of Plan. The Plan will terminate
ten (10) years from January 31, 2016.

19.       

Amendment
or Termination of Plan. The Board may at any time terminate or amend the Plan in any respect, including without limitation amendment
of any form of Award Agreement or instrument to be executed pursuant to the Plan; provided, however, that: (a) the Board shall
not, without the approval of the shareholders of the Company, amend the Plan in any manner that requires such shareholder approval
pursuant to the Code or the regulations promulgated thereunder as such provisions apply to ISO plans or pursuant to the Exchange
Act or Rule 16b-3 (or its successor), as amended, thereunder; and (b) no outstanding Award shall be deemed effected by such amendment
without the advance written consent of the Participant(s) holding such outstanding Award(s) at the time of the proposed termination
or amendment.

20.       

Non-exclusivity
of the Plan. Neither the adoption of the Plan by the Board, the submission of the Plan to the shareholders of the Company for approval,
nor any provision of the Plan shall be construed as creating any limitations on the power of the Board to adopt such additional
compensation arrangements as it may deem desirable, including, without limitation, the granting of stock options and bonuses otherwise
than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases.

    	 

    	 

    

 

21.       

Definitions. As used in the Plan,
the following terms shall have the following meanings:

“Affiliate” means
any corporation that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common
control with, another corporation, where “control” (including the terms “controlled by” and “under
common control with”) means the possession, direct or indirect, of the power to cause the direction of the management and
policies of the corporation, whether through the ownership of voting securities, by contract or otherwise.

“Award” means any award
under the Plan, including any Option or Restricted Stock.

“Award Agreement”
means, with respect to each Award, the signed written agreement between the Company and the Participant setting forth the terms
and conditions of the Award.

“Board” means the Board
of Directors of the Company.

“Code” means the Internal
Revenue Code of 1986, as amended.

“Committee” means
a committee appointed by the Company’s Compensation Committee (said Compensation Committee itself being first appointed by
the Company’s Board).

“Company” means EMR
TECHNOLOGY SOLUTIONS, INC., a Nevada corporation, or any successor company.

“Disability” means
a disability, whether temporary or permanent, partial or total, as determined by the Committee.

“Disinterested Person”
means a director who has not, during the period that person is a member of the Committee and for one (1) year prior to service
as a member of the Committee, been granted or awarded equity securities pursuant to the Plan or any other plan of the Company or
any Parent, Subsidiary or Affiliate of the Company, except in accordance with the requirements set forth in Rule 16b-3(c) (2)(1)
(and any successor regulation thereto) as promulgated by the SEC under Section 16(b) of the Exchange Act, as such rule is amended
from time to time and as interpreted by the SEC.

“Exchange Act” means
the Securities Exchange Act of1934, as amended.

“Exercise Price”
means the price at which a holder of an Option may purchase the Shares issuable upon exercise of the Option.

“Fair Market Value”
means, as of any date, the value of a share of the Company’s Common Stock determined as follows:

(a)       

if such
Common Stock is then quoted on the Nasdaq market, its last reported sale price on the Nasdaq market or, if no such reported sale
takes place on such date, the average of the closing bid and asked prices;

    	 

    	 

    

 

(b)       

if such
Common Stock is publicly traded and is then listed on a national securities exchange, the last reported sale price or, if no such
reported sale takes place on such date, the average of the closing bid and asked prices on the principal national securities exchange
on which the Common Stock is listed or admitted to trading;

(c)       

if such
Common Stock is publicly traded but is not quoted on a Nasdaq market nor listed or admitted to trading on a national securities
exchange, the average of the closing bid and asked prices on such date, as reported by The Wall Street Journal, for the over-the-counter
market; or

(d)       

if none
of the foregoing is applicable, by the Board of Directors of the Company in good faith.

“Insider” means
an officer or director of the Company or any other person whose transactions in the Company’s Common Stock are subject to
Section 16 of the Exchange Act.

“Option” means an award
of an option to purchase Shares pursuant to Section 5.

“Parent” means any
corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if at the time of the granting
of an Award under the Plan, each of such corporations other than the Company owns stock possessing fifty percent (50%), or more,
of the total combined voting power of all classes of stock in one of the other corporations in such chain.

“Participant” means a
person who receives an Award under the Plan.

“Plan” means this
EMR Technology Solutions, Inc. Equity Incentive Plan, as amended from time to time.

“SEC” means the
Securities and Exchange Commission. “Securities Act” means the Securities Act of 1933, as amended.

“Shares” means shares
of the Company’s Common Stock reserved for issuance under the Plan, as adjusted pursuant to Sections 2 and 17, and any successor
security.

“Subsidiary” means
any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company i:t: at the time of granting
of the Award, each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent
(50%), or more, of the total combined voting power of all classes of stock in one of the other corporations in such claim.

“Termination” or
“Terminated” means, for purposes of the Plan with respect to a Participant, that the Participant has ceased to provide
services as an employee, director, consultant or advisor, to the Company or a Parent, Subsidiary or Affiliate of the Company, except
in the case of sick leave, military leave, or any other leave of absence approved by the Committee, provided, that such leave is
for a period of not more than ninety (90) days, or reinstatement upon the expiration of such leave is guaranteed by contract or
statute. The Committee shall have sole discretion to determine whether a Participant has ceased to provide services and the effective
date on which the participant ceased to provide services (the ‘‘Termination Date”).

    	 

    	 

    

 

EXERCISE NOTICE

EMR TECHNOLOGY SOLUTIONS, INC.

90 Washington Valley Road

Bedminster, NJ 07921

Attention: Stock Option Plan Administrator

1.       

Exercise
of Option. Effective as of today, the undersigned (“Participant’) hereby elects to exercise Participant’s option
to purchase ____________ shares of the Common Stock (the “Stock “) of EMR Technology Solutions, Inc. (the “Company”)
under and pursuant to the EMR Technology Solutions, Inc. Equity Incentive Plan (the ‘‘Plan and the Stock Option Agreement
dated January 31, 2016 (the “Option Agreement”)

2.       

Delivery
of Payment. Purchaser herewith delivers to the Company the full purchase price of the Shares, as set forth in the Option Agreement.

3.       

Representations
of Participant. Participant acknowledges that Participant has received, read and understood the Plan and the Option Agreement and
agrees to abide by and be bound by their terms and conditions.

4.       

Rights as
Shareholder. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized
transfer agent of the Company), no right to vote or receive dividends or any other rights as a shareholder shall exist with respect
to the Optioned Stock, notwithstanding the exercise of the Option. The Shares shall be issued to the Participant as soon as practicable
after the Option is exercised.

5.       

Tax Consultation.
Participant understands that Participant may suffer adverse tax consequences as a result of Participant’s purchase or disposition
of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection
with the purchase or disposition of the Shares and that Participant is not relying on the Company for any tax advice.

6.       

Successors
and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise
Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein
set forth, this Exercise Notice shall be binding upon Participant and his or her heirs, executors, administrators, successors and
assigns.

7.       

Withholding
Taxes. There may be a regular federal income tax liability upon the exercise of this Option. Participant will be treated as having
received compensation income (taxable at ordinary income tax rates) equal to the excess, if any, of the Fair Marl<:et Value
of the Shares on the date of exercise over the Exercise Price. If Participant is an employee, the Company will be required to withhold
from Participant’s compensation or collect from Participant and pay to the applicable taxing authorities an amount equal
to a percentage of this compensation income at the time of exercise.

8.       

Governing
Law. This Exercise Notice is governed by the internal substantive laws of the State of Nevada.

    	 

    	 

    

 

9.       

Entire Agreement.
The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan, the Option Agreement constitute
the entire agreement ofthe parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings
and agreements of the Company and Participant with respect to the subject matter hereof; and may not be modified adversely to the
Participant’s interest except by means of a writing signed by the Company and Participant.

	Submitted by:	 	Accepted by:
	 	 	 
	PARTICIPANT	 	EMR TECHNOLOGY SOLUTIONS, INC.
	 	 	 
	 	 	 
	Signature	 	By:
	Name:	 	Title:EMR Technology Solutions, Inc. - 10-12G/A

Exhibit 4.2

 

THIS
NOTE AND THE SHARES OF COMMON STOCK ACQUIRABLE ON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND MAY NOT BE SOLD, OFFERED FOR SALE, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR
AN OPINION OF COUNSEL, WHICH COUNSEL AND OPINION SHALL BE SATISFACTORY TO THE CORPORATION, THAT SUCH REGISTRATION IS NOT REQUIRED.

 

CONVERTIBLE
PROMISSORY NOTE

 

	***$700,000.00***	BEDMINSTER,
    NEW JERSEY

 

FOR
VALUE RECEIVED, the undersigned, EMR TECHNOLOGY SOLUTIONS, INC., a Nevada corporation (the “Corporation”), agrees
and promises to pay to the order of Denis Salins (the “Holder”), c/o First Medical Solutions Corporation, 6524 NW
55th Street, Coral Springs, Florida 33067, or at such other place or places as the Holder may designate in writing, the principal
amount of SEVEN HUNDRED THOUSAND ($700,000) DOLLARS, as follows:

 

1.       Interest
Only Payments. Commencing on December 31, 2016 and on the last day of the next seven (7) consecutive calendar quarters
thereafter, the Corporation shall make an interest payment calculated at the rate of ten (10.00%) percent per annum on the outstanding
principal balance.

 

2.       Principal
Reduction. The Corporation shall repay the principal balance due and owing along with accrued interest thereon calculated
at the rate of 10.00% per annum in four (4) equal quarterly installments on each of December 31, 2018, March 29, 2019, June 28,
2019 and September 30, 2019. The entire principal balance plus all accrued interest shall be due and payable on or before September
30, 2019 (the “Maturity Date”). Interest shall be computed on the basis of a year consisting of twelve (12) months
of thirty (30) days each. All payments shall be made in lawful money of the United States of America. Payment shall be credited
first to the accrued interest then due and payable and the remainder applied to principal.

 

3.       Prepayment.
The Corporation may, at its option, prepay this Note, in whole or in part, at any time prior to the Maturity Date, without
penalty. Any prepayment shall first be applied to any outstanding interest due and payable, then to the principal balance in the
inverse order of payment.

 

4.       Credits
and Adjustments. The principal amount of this Note shall be subject to certain credits and adjustments in accordance with
Section 1.8 of a certain Stock Purchase Agreement (the “Purchase Agreement”) dated of even date herewith. Negative
adjustments pursuant to Section 1.8 of the Purchase Agreement shall be treated as a credit against principal payments due hereunder,
but in the inverse order of such payments.

 

5.       Late
Payments; Default Rate. If the Corporation fails to make any payment of principal, interest or other amount coming
due pursuant to the provisions of this Note within ten (10) calendar days of the date due and payable, the Corporation also
shall pay to the Holder a late charge equal to five percent (5%) of the amount of such payment. Such five day period shall
not be construed in any way to extend the due date of any such payment. The late charge is imposed for the purpose of
defraying the Holder’s expenses incident to the handling of delinquent payments and is in addition to, and not in lieu
of, the exercise by the Holder of any rights and remedies hereunder, under the other Loan Documents or under applicable laws,
and any fees and expenses of any agents or attorneys which the Holder may employ.

 

    PROMISSORY NOTE

     

    

 

6.       Events
of Default. The occurrence of any of the following events will be deemed to be an “Event of Default” under
this Note: (i) the nonpayment of any principal, interest or other indebtedness under this Note within ten (10) days of written
notice of default; (ii) the occurrence of any event of default or default and the lapse of any notice or cure period under this
Note or the Source Code Escrow Agreement ; (iii) the filing by or against the Corporation of any proceeding in Bankruptcy, receivership,
insolvency, reorganization, liquidation, conservatorship or similar proceeding (and, in the case of any such proceeding instituted
against the Corporation, such proceeding is not dismissed or stayed within thirty (30) days of the commencement thereof); (iv)
any assignment by the Corporation for the benefit of creditors, or any levy, garnishment, attachment or similar proceeding is
instituted against any property of the Corporation held by or deposited with the Lender; (v) the commencement of any foreclosure
or forfeiture proceeding, execution or attachment against any collateral securing the obligations of the Corporation to the Holder;
or (vi) the Corporation ceases doing business as a going concern.

 

Upon
the occurrence of an Event of Default: (a) If an Event of Default specified in clause (iii) or (iv) above shall occur, the
outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder shall be
immediately due and payable without demand or notice of any kind; (b) if any other Event of Default shall occur, the
outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder, at the
option of the Holder and without demand or notice of any kind, may be accelerated and become immediately due and payable; and
(c) the Holder may exercise from time to time any of the rights and remedies available to the Holder under applicable
law.

 

7.       Collateral
Security. The Corporation’s obligations hereunder shall be secured by the escrow of the Source Code (as defined in the
Purchase Agreement) pursuant to the terms of a certain Technology Escrow Agreement dated the date hereof (the “Escrow Agreement”).
Any breach or default under this Promissory Note shall be deemed to be a default under the Escrow Agreement and, conversely, any
breach or default under the Escrow Agreement shall be deemed to be a default under this Promissory Note.

 

8.       Miscellaneous.
No delay or omission of the Holder to exercise any right or power arising hereunder shall impair any such right or power or
be considered to be a waiver of any such right or power, nor shall the Holder’s action or inaction impair any such right
or power. The Corporation agrees to pay on demand, to the extent permitted by law, all costs and expenses incurred by the Holder
in the enforcement of its rights in this Note and in any security therefor, including without limitation reasonable fees and expenses
of the Holder’s counsel. If any provision of this Note is found to be invalid by a court, all the other provisions of this
Note will remain in full force and effect. The Corporation hereby forever waives presentment, protest, notice of dishonor and
notice of non-payment. The Corporation also waives all defenses based on suretyship or impairment of collateral. This Note shall
bind the Corporation and its heirs, executors, administrators, successors and assigns of the Corporation and the benefits hereof
shall inure to the benefit of the Holder and its successors and assigns.

 

    	 	 2	PROMISSORY NOTE

     

    

 

9.       No
Setoff. The obligations of the Corporation to pay the principal balance and interest due to the Holder shall be absolute
and unconditional, and the Corporation shall make such payment without abatement, diminution or deduction regardless of any cause
or circumstances whatsoever, including, without limitation, any defense, setoff, recoupment, or counterclaim which the Corporation
may have or assert against the Holder or any other person,. Notwithstanding what is set forth above, Maker shall be entitled to
deduct and set off from sums due to the Holder hereunder, any damages or costs arising from obligations of First Medical Solutions
Corporation incurred prior to the closing date pursuant to the terms contained within the Stock Purchase executed between Maker
and Holder of even date herewith. Maker’s right of set-off shall only occur after providing Holder with written notice
of such claim and an opportunity to pay or dispute said claim.

 

10.    Conversion.
The Holder may, at any time prior to the Maturity Date, convert the remaining principal balance of this Note, plus any
accrued interest, or any portion thereof, into fully paid and non-assessable shares of the common stock, no par value, of the
Corporation (the “Common Stock”), on the basis of one share of such stock for each Three Dollars ($3.00) (the “Conversion
Price”) in unpaid principal and/or interest. Such conversion shall be effected by the surrender of this Note at the principal
office of the Corporation (or such other office or agency of the Corporation in the continental United States as the Corporation
may designate by notice in writing to the Holder) at any time during usual business hours, together with notice in writing that
the Holder wishes to convert a portion or all of this Note, which notice shall also state the name(s) (with addresses) and denominations
in which the certificate(s) for Common Stock shall be issued and shall include instructions for delivery thereof. Such conversion
shall be deemed to have been effected as of the close of business on the date on which this Note shall have been surrendered and
such notice shall have been received, and at such time (the “Voluntary Conversion Date”) the rights of the Holder
with respect to the principal amount of the Note converted shall cease and the person(s) in whose name(s) any certificate(s) for
Common Stock are to be issued upon such conversion shall be deemed to have become the holder or holders of record of the shares
of Common Stock represented by such certificate(s). As soon as practicable after the Voluntary Conversion Date, the Corporation
shall deliver to, or as directed by, the Holder, certificates representing the number of shares of Common Stock issuable by reason
of such conversion registered in such name or names and such denomination or denominations as the Holder shall have specified,
together with cash as provided in Section 14 in respect of any fraction of a share of such stock otherwise issuable upon such
conversion. In each case of conversion of this Note in part only, the Corporation shall receive and hold this Note as a fiduciary
agent of the Holder, shall endorse on this Note the date and amount of this Note so converted, and such amount shall be deemed
no longer outstanding. Upon such endorsement, the Corporation shall promptly return this Note to the Holder.

 

11.    Reservation
of Common Stock.

 

(a)       The
Corporation will at all times from and after this date reserve and keep available out of its authorized but unissued shares of
Common Stock or its treasury shares, or otherwise, solely for the purpose of issuance upon the conversion of this Note, such number
of shares of Common Stock as shall then be issuable upon the conversion of this Note. The Corporation covenants that all shares
of Common Stock which shall be so issuable shall, when issued, be duly and validly issued, fully paid and nonassessable and free
from all taxes, liens and charges.

  

    	 	 3	PROMISSORY NOTE

     

    

 

(b)       The
Corporation will not take any action which would result in any adjustment of the number of shares of Common Stock acquirable upon
conversion of this Note if the total number of shares issuable after such action upon conversion of this Note, together with the
total number of shares of Common Stock then outstanding, would exceed the total number of shares of Common Stock then authorized
under the Corporation’s Certificate of Incorporation which are not reserved or required to be reserved for any purpose other
than the purpose of issue upon conversion of this Note.

 

(c)       The
issuance of certificates for shares of Common Stock upon conversion of this Note shall be made without charge to the Holder for
any issuance tax or other cost incurred by the Corporation in connection with such conversion and the related issuance of shares
of Common Stock.

 

(d)       If
any shares of Common Stock required to be reserved for purposes of conversion of this Note require, before such shares may be
issued upon conversion, registration with or approval of any governmental authority under any federal or state law (other than
any registration under the Securities Act of 1933, as then in effect, or any similar federal statute then in force, or any state
securities law, required by reason of any transfer involved in such conversion) or listing on any domestic securities exchange,
the Corporation will, at its expense and as expeditiously as possible, use its best efforts to cause such shares to be duly registered
or approved for listing or listed on such domestic securities exchange, as the case may be.

 

		12.	Subdivisions
                                         and Combinations.

 

(a)       In
the event the Corporation shall at any time subdivide by any stock split its outstanding Common Stock into a greater number of
shares of such stock, the Conversion Price shall be proportionately decreased. Conversely, in the event the outstanding shares
of one or more classes of Common Stock shall at any time be combined into a smaller number of shares by a reverse stock split,
the Conversion Price shall be proportionately increased. In the case of any subdivision or combination described in this Section
11, the adjustment to be made pursuant hereto shall be made as of the close of business on the date immediately prior to the date
upon which such corporate action becomes effective.

 

(b)       No
Adjustment for Small Amounts. Notwithstanding any contrary provision of subsection (a) of this Section 12, the Corporation shall
not be required to give effect to any adjustment to the Conversion Price if the amount of such adjustment would be less than $.01,
but any such adjustment shall be carried forward and adjustment with respect thereto shall be made at the time of and together
with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, causes a cumulative
net adjustment of $.03 or more.

 

    	 	 4	PROMISSORY NOTE

     

    

 

(c)       Organic
Changes, Etc. If any capital reorganization or reclassification of the capital stock of the Corporation (other than a change in
par value, or from par value to no par value, or from no par value to par value, or as a result of an issuance of Common Stock
by dividend or other distribution or by reason of a subdivision or combination), or any consolidation or merger of the Corporation
with or into another corporation, or any sale of all or substantially all of the Corporation’s property and assets to any
person, firm or corporation (collectively, any “Organic Change”) shall be effected in such a way that holders of Common
Stock shall be entitled to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to
or in exchange for Common Stock, then, as a condition to such Organic Change, lawful and adequate provision shall be made whereby
the Holders shall thereafter have the right to acquire and receive upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock of the Corporation immediately theretofore acquirable and receivable (directly
or upon subsequent conversion, assuming unrestricted convertibility) upon the conversion of this Note, such shares of stock, securities
or assets as may be issued or payable with respect to or in exchange for a number of outstanding shares of Common Stock equal
to the number of shares of Common Stock immediately theretofore acquirable and receivable (directly or upon subsequent conversion,
assuming unrestricted convertibility) upon conversion of this Note had such Organic Change not taken place (except that the terms
of the parenthetical provision at the end of the next sentence shall be applied in determining the number of shares of Common
Stock immediately theretofore acquirable and receivable). In any such case, appropriate provision shall be made with respect to
the Holder’s rights and interests to the end that the provisions contained in this Note (including without limitation provisions
for adjustments of the number of shares of Common Stock acquirable and receivable upon the exercise of the conversion rights granted
herein) shall thereafter be applicable in relation to any shares of stock, securities or assets thereafter deliverable upon the
conversion of this Note (including, in the case of any such consolidation, merger or sale in which the successor corporation or
purchasing entity is other than the Corporation, an immediate adjustment in the number of shares of Common Stock acquirable and
receivable upon conversion of this Note). In the event of a merger or consolidation of the Corporation with or into another corporation
or the sale of all or substantially all of the Corporation’s property and assets to another corporation as a result of which
a number of shares of common stock of the surviving or purchasing corporation greater or lesser than the number of shares of Common
Stock of the Corporation outstanding immediately prior to such merger, consolidation or sale are issuable to holders of Common
Stock, the aggregate number of shares of Common Stock into which this Note was convertible in effect immediately prior to such
merger, consolidation or sale shall be adjusted (pursuant to Subsection (a) of this Section 11) as though there were a subdivision
or combination of the outstanding shares of Common Stock. The provisions of this subsection (c) shall similarly apply to successive
Organic Changes.

 

		13.	Notice
                                         of Adjustment.

 

(a)       Immediately
upon any adjustment in the number of shares of Common Stock acquirable and receivable upon conversion of this Note or any adjustment
or readjustment in the Conversion Price, the Corporation shall send written notice to the Holder, which notice shall set forth
in reasonable detail the method of calculation and the facts upon which such calculation is based. The Corporation shall, upon
written request at any time of any holder of the Convertible Note, furnish or cause to be furnished to such holder a similar certificate
setting forth (i) such adjustments and readjustments, (ii) the Conversion Price then in effect, and (iii) the number of shares
of Common Stock and the amount, if any, of other property which then would be received upon the conversion of the Convertible
Note. The Corporation may retain a firm of independent public accountants of recognized standing which may be the firm regularly
retained by the Corporation to make any computation required under this Section and a certificate signed by such firm shall be
conclusive evidence of the correctness of any computation made under this Section.

 

    	 	 5	PROMISSORY NOTE

     

    

 

		(b)	In the
                                         event that:

 

		(i)	there
                                         is any proposed combination or subdivision of the outstanding shares of Common Stock;

 

		(ii)	there
                                         shall be any proposed Organic Change; or

 

		(iii)	there
                                         shall be any proposed voluntary or involuntary dissolution, liquidation or winding up
                                         of the Corporation;

 

then
in connection with each such event, the Corporation shall send to the Holder: (A) at least sixty (60) days prior written notice
of the date on which the books of the Corporation shall close or a record shall be taken for determining voting rights in respect
of such event; and (B) in the case of any proposed Organic Change, dissolution, liquidation or winding up, at least sixty (60)
days prior written notice of the date when the same shall take place (and specifying the date on which the holders of Common Stock
shall be entitled to exchange their Common Stock for securities or other property deliverable upon such Organic Change, dissolution,
liquidation or winding up).

 

14.    Fractional
Interests. The Corporation shall not be required to issue any fractional shares of Common Stock on the conversion of this
Note. If any fraction of a share of Common Stock would be issuable upon conversion of this Note, the Corporation shall purchase
such fraction for an amount in cash equal to the current market price of such fraction on the last Business Day prior to conversion.

 

15.    Voting.
Nothing contained in this Note shall be construed as conferring upon the Holder the right to vote or to consent or to
receive notice as a stockholder in respect of the meetings of stockholders for the election of directors of the Corporation or
any other matter. Notwithstanding the foregoing, the Corporation shall mail by first class to the Holder, at the address first
specified above, one copy of all materials forwarded to stockholders, said mailing to be made promptly after mailing to stockholders.

 

16.    Notices.
Any notice required or permitted by this Note shall be in writing and shall be deemed sufficient upon delivery, when delivered
personally or by a nationally-recognized delivery service (such as Federal Express or UPS), or forty-eight (48) hours after being
deposited in the U.S. mail, as certified or registered mail, with postage prepaid, addressed to the party to be notified at such
party’s address as set forth above or as subsequently modified by written notice.

 

17.    Governing
Law; Venue; Jurisdiction. This Note shall be governed by and construed in accordance with the internal laws of the State
of New Jersey. The Corporation hereby irrevocably submits to the exclusive jurisdiction of the federal or state court sitting
in New Jersey over any dispute arising out of or relating to this Note. The Corporation hereby irrevocably waives, to the fullest
extent permitted by applicable law, any objection which it may now or hereafter have to the laying of venue of any such dispute
brought in such court or any defense of inconvenient forum for the maintenance of such dispute. The Corporation agrees that a
judgment in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
law. The Corporation consents to process being served in any suit, action or proceeding hereunder by the mailing of a copy thereof
in accordance with the notice provisions of this Note.

 

    	 	 6	PROMISSORY NOTE

     

    

 

18.       Modification.
No modification or waiver of any provision of this Note, or any departure by the Corporation therefrom, shall in any event
be effective unless the same shall be in writing signed by the Holder, and then such modification or waiver shall be effective
only in the specific instance for the specific purpose given.

 

19.       Waiver
of Jury Trial. The Corporation irrevocably waives any and all rights the Corporation may have to a trial by jury in any
action, proceeding or claim of any nature relating to this note, any documents executed in connection with this note or any transaction
contemplated in any loan documents. The Corporation acknowledges that the foregoing waiver is knowing and voluntary.

 

	Dated: September 23, 2016	 	
	 	 	 
	 	 	EMR Technology Solutions, Inc.
	Attest:	 	 	 
	/s/
     Lowell T. Holden	 	By:	/s/
    John X. Adiletta 
	Name: Lowell T. Holden,	 	 	Name: John X. Adiletta
	Title: Secretary	 	 	Title: Chief Executive Officer
	 	 	 	 

  

    	 	 7	PROMISSORY NOTE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]